Global Antisense and RNAi Therapeutics Market 2021-2025

Global Antisense And RNAi Therapeutics Market 2021-2025

The publisher has been monitoring the antisense and rnai therapeutics market and it is poised to grow by $ 1.61 bn during 2021-2025 progressing at a CAGR of 8% during the forecast period. The report on antisense and rnai therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high target affinity and specificity of RNAi therapeutics and availability of delivery platforms like nanoparticles and conjugates. In addition, high target affinity and specificity of RNAi therapeutics is anticipated to boost the growth of the market as well.

The antisense and rnai therapeutics market analysis includes type segment, application segment and geographical landscapes.

The antisense and rnai therapeutics market is segmented as below:

By Type

• antisense therapy
• RNAi therapy

By Geography

• North America
• Europe
• Asia
• ROW

By Application

• infectious diseases
• cardiovascular diseases
• cancer
• metabolic disorder
• others

This study identifies ease of standardization and large-scale manufacturing as one of the prime reasons driving the antisense and rnai therapeutics market growth during the next few years. ease of standardization and large-scale manufacturing will lead to sizable demand in the market.

The report on antisense and rnai therapeutics market covers the following areas:

• Antisense and rnai therapeutics market sizing
• Antisense and rnai therapeutics market forecast
• Antisense and rnai therapeutics market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antisense and rnai therapeutics market vendors that include Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Bausch Health Companies Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Sanofi, and Sarepta Therapeutics Inc.. Also, the antisense and rnai therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.